Abiopharma

Clinical trial NCT06450197: primary completion date: 2026-05-01 → 2026-04-30.

Clinical trial NCT06018337 updates: 1. completion date: 2028-07-01 → 2028-08-01 2. primary completion date: 2026-05-01 → 2026-06-01

Arch Capital Group Ltd. Announces Cash Tender Offers to Purchase up to a Capped Amount of Certain of Its Subsidiaries’ Debt Securities

Notification from Dominari Holdings Inc

Corsica Utility to Support Its Conservation Goals With Itron’s Smart Water Solution

RenX Posts Record Delivery Quarter at Myakka City, Up 57%; Independent Drone Survey Verifies Approximately 185,000 Cubic Yards On-Site

$170 Billion in Border and Security Funding Highlights Growing Demand for AI-Powered Surveillance and Machine Vision Technologies

Net Asset Value(s)

Envirotech Vehicles, Inc. (NASDAQ: EVTV) Builds out 500 MW Energy-Backed Infrastructure Platform Across 548-Acre Campus to Power Artificial Intelligence and Data Center Growth

Genius Group Completes First Investments for its AI Treasury with Pre-IPO exposure to SpaceX, Anthropic and OpenAI